Therefore, this study aimed to reveal the changes in early brain structure, function, and metabolism of APP/PS1 transgenic mice through the combined application of multimodal MRI technology of sMRI, rs-fMRI, and 1H-MRS, providing animal level basis for searching for imaging biomarkers for early diagnosis of AD. This evidence concerns the gene APP and Alzheimer disease.